{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:53:25Z","timestamp":1789458805707,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-00544"],"award-info":[{"award-number":["2022-00544"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006636","name":"Forskningsr\u00e5det f\u00f6r h\u00e4lsa, arbetsliv och v\u00e4lf\u00e4rd","doi-asserted-by":"publisher","award":["2024-01652"],"award-info":[{"award-number":["2024-01652"]}],"id":[{"id":"10.13039\/501100006636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005423","name":"Uppsala University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","award":["22 2051"],"award-info":[{"award-number":["22 2051"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.euros.2026.05.006","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:23:28Z","timestamp":1779377008000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy"],"prefix":"10.1016","volume":"89","author":[{"given":"Pietro","family":"Scilipoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Callenmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Garmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Gedeborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-6967","authenticated-orcid":false,"given":"Marcus","family":"Westerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2026.05.006_b0005","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jnci\/djaf012","article-title":"Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study","volume":"117","author":"Scilipoti","year":"2025","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.euros.2026.05.006_b0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.eururo.2019.03.016","article-title":"External validation of the European Association of Urology biochemical recurrence risk groups to predict metastasis and mortality after radical prostatectomy in a European cohort","volume":"75","author":"Tilki","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.006_b0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.006_b0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euros.2026.05.006_b0025","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41391-024-00894-0","article-title":"Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment","volume":"28","author":"Freedland","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.euros.2026.05.006_b0030","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bjmsu.2011.08.006","article-title":"PSA velocity and doubling time in diagnosis and prognosis of prostate cancer","volume":"5","author":"Vickers","year":"2012","journal-title":"Br J Med Surg Urol"},{"key":"10.1016\/j.euros.2026.05.006_b0035","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2008.19.9794","article-title":"Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy","volume":"27","author":"O'Brien","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euros.2026.05.006_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaf172","article-title":"Cohort profile update: the national prostate cancer Register of Sweden and PCBase","volume":"54","author":"Westerberg","year":"2025","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.euros.2026.05.006_b0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN Guidelines\u00ae insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euros.2026.05.006_b0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/21681805.2022.2093396","article-title":"The Swedish national guidelines on prostate cancer, part 2: Recurrent, metastatic and castration resistant disease","volume":"56","author":"Bratt","year":"2022","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euros.2026.05.006_b0055","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3109\/0284186X.2014.939299","article-title":"Capture rate and representativity of the National Prostate Cancer Register of Sweden","volume":"54","author":"Tomic","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euros.2026.05.006_b0060","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/cncr.21696","article-title":"Critical analysis of prostate\u2010specific antigen doubling time calculation methodology","volume":"106","author":"Svatek","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2026.05.006_b0065","first-page":"473","article-title":"Implication of cell kinetic changes during the progression of human prostatic cancer","volume":"1","author":"Berges","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euros.2026.05.006_b0070","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/1097-0142(19930315)71:6<2031::AID-CNCR2820710618>3.0.CO;2-Q","article-title":"Observations on the doubling time of prostate cancer. The use of serial prostate\u2010specific antigen in patients with untreated disease as a measure of increasing cancer volume","volume":"71","author":"Schmid","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.euros.2026.05.006_b0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.eururo.2013.03.006","article-title":"Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification","volume":"64","author":"Abdollah","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2026.05.006_b0080","doi-asserted-by":"crossref","first-page":"163.e7","DOI":"10.1016\/j.urolonc.2014.11.018","article-title":"Natural history of surgically treated high-risk prostate cancer","volume":"33","author":"Briganti","year":"2015","journal-title":"Urol Oncol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326005057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168326005057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:27:55Z","timestamp":1783110475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168326005057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"alternative-id":["S2666168326005057"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.006","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical Prostatectomy","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2026.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}